Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease
Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease
Survivors and oncology professionals share their stories with lawmakers to underscore the importance of insurance coverage of cutting-edge biomarker testing
Volunteer advocates, including cancer survivors, patients,
In a new, large national study published today in the Journal of the American Medical Association (JAMA) Network Open, American Cancer Society (ACS) researchers found the 2018 federal policy loosening restrictions on STLD insurance plans was associated with an increase in late-stage cancer diagnoses in states without or with inadequate additional STLD plan regulatory protections.
Last week, the Senate and House voted to advance Senate Bill 773 and House Bill 1246, legislation which seeks to create more stability for patients by curbing an unfair insurance practice that makes critical medication more expensive and access unpredictable. The passage of each bill in their respective chambers, which now await concurrence voting, came on the heels of the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day when cancer survivors, patient advocates and medical professionals traveled to Annapolis to discuss the importance of this legislation in ensuring access to lifesaving prescription drugs. Advocates are hopeful that lawmakers see the bills’ momentum as a call to action to take the final steps to pass and enact the necessary reforms.
El Senado estatal aprobó unánimemente una legislación que eliminaría los costos compartidos para los exámenes de detección del cáncer de pulmón y las pruebas de seguimiento para las personas elegibles con un seguro médico regulado por el estado, incluido Medicaid.
A statement from John Manna, Jr., Esq., Vice Chair of the American Cancer Society Cancer Action Network Board of Directors and constituent of former U.S. Rep. Nita Lowey, on her passing.
Activistas de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer lamentan la pérdida del Rep. Raúl Grijalva, quien falleció el jueves debido a complicaciones causadas por un cáncer de pulmón.
SALEM, Oregon —— Jane Leo has been named the American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director for Oregon.
Volunteer advocates, including cancer survivors, patients, and caregivers from across Colorado convened at the state capitol for ‘Cancer Action Day’ Wednesday, an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Volunteer advocates met with lawmakers and discussed supporting access to care and sustaining funding for tobacco prevention and cessation.